Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The Food and Drug Administration on Thursday approved Pfizer's leukemia drug Besponsa, reports Reuters.
Stryker on Wednesday earned Food and Drug Administration clearance for its Serrato Pedicle Screw.
You have adopted an innovative mindset and are thinking outside of the box about supply chain management– what’s next? Execute.
Mike Duffy, President of Hospital Solutions and Global Supply Chain at Cardinal Health
Here are seven articles published by Becker's Hospital Review in the last week, which highlight a nationwide depletion of Sanofi Pasteur's yellow fever vaccine, Intermountain's 2014 Supplier Award winners and more.
Mylan on Thursday finalized a $465 million settlement with the federal government over accusations the Canonsburg, Pa.-based drugmaker improperly classified EpiPens as a generic drug to overcharge Medicaid, reports CNBC.
The supply of Sanofi Pasteur's yellow fever vaccine — the only such immunization licensed in the U.S. — is completely depleted and will remain out of stock until mid-2018, according to the CDC.
Maersk Line, a Danish shipping conglomerate, may have lost up to $300 million in revenue following a global cyberattack, reports ZDNet.
Amazon's plan to launch instant pickup points in the U.S. may help shoppers quickly access prescriptions, one health expert told CNBC.
Numerous fast-tracked drugs and updated medical devices lack sufficient follow-up data to ensure their safety and efficacy, according to two separate studies published Aug. 15 in JAMA.
Amneal Pharmaceuticals on Monday issued a voluntary recall of its Lorazepam Oral Concentrate solution over issues with the droppers packaged with the medication.